Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland

Publisher： Karger

E-ISSN： 1421-9913|63|2|101-106

ISSN： 0014-3022

Source： European Neurology, Vol.63, Iss.2, 2010-01, pp. : 101-106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity

By  

European Neurology, Vol. 71, Iss. 5-6, 2014-02 ,pp. : 271-279

Karger

Access to resources Recommend Favorite

Expression of Th1/Th2-Related Chemokine Receptors on Peripheral T Cells and Correlation with Clinical Disease Activity in Patients with Multiple Sclerosis

By  

European Neurology, Vol. 52, Iss. 3, 2004-11 ,pp. : 162-168

Karger

Access to resources Recommend Favorite

Correlation between MRI and Short-Term Clinical Activity in Multiple Sclerosis: Comparison between Standard- and Triple-Dose Gd-Enhanced MRI

By  

European Neurology, Vol. 41, Iss. 3, 1999-04 ,pp. : 123-127

Karger

Access to resources Recommend Favorite

From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study

By  

European Neurology, Vol. 71, Iss. 5-6, 2014-01 ,pp. : 233-241

Karger

Access to resources Recommend Favorite

Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple Sclerosis

By  

Neuroepidemiology, Vol. 45, Iss. 2, 2015-0 ,pp. : 83-89

Karger

Access to resources Recommend Favorite